Skip to main content
. 2015 Jan 28;2015(1):CD010632. doi: 10.1002/14651858.CD010632.pub2

Nobili 2008.

Study characteristics
Patient sampling 36 participants with memory complaints in whom an objective memory deficit was demonstrated by means of neuropsychological tests and 17 healthy volunteers who gave their informed consent were recruited during university courses dedicated to elderly people. Sampling procedure not described. We only include data on performance of the index test to discriminate between people with MCI who converted to dementia and those who remained stable.
Excusion criteria: presence of analphabetism, major vision disturbances, psychiatric illnesses, epilepsy, major head trauma, Parkinsonism, previous stroke or TIA and brain masses; people scoring higher than 0 on the delusion and the hallucination NPI items were excluded.
Patient characteristics and setting 36 participants with MCI, diagnosed with the Petersen 2004 criteria at baseline, were recruited from the Outpatient clinic. Demographic characteristics are reported for 33 participants who were included in the analysis.
Gender: converters: 11 women, 11 men; non‐converters: 9 women, 2 men
Age: converters: 77.3 ± 4.8 years; non‐converters: 74.6 ± 5.4 years
APOEɛ4: not reported on all MCI participants.
converters: 4/8 (50%); non‐converters: 5/14 (36%)
MMSE: converters: 27.6 ± 1.4; non‐converters: 27.4 ± 2.0
Education: converters: 8.5 ± 3.9; non‐converters: 8.8 ± 4.7
Sources of referral: not reported
Sources of recruitment: outpatients, no further information
Index tests ¹⁸F‐FDG PET scan
The index test was performed within 3 months from the clinical–neuropsychological examination (mean 29.9 days in participants and 29.8 days in controls). Participants fasted for at least 6 hours. Before radiopharmaceutical injection, blood glucose was checked and was < 140 mg/dl in all cases. After a 10‐min rest in a silent and obscured room, with eyes closed and ears unplugged, participants were injected with approximately 370 MBq of ¹⁸F‐FDG PET via a venous cannula, according to the guidelines of the European Association of Nuclear Medicine (Bartenstein 2002). They remained in the room for 30 mins after injection, and were then moved to the PET room where scanning started approximately 45 mins after injection and lasted 20 mins.
Threshold: not reported; visual interpretation ‐ 25 VROI (volumetric region of interest).
Index test was conducted before follow‐up.
Target condition and reference standard(s) Target condition: conversion from MCI to Alzheimer's disease dementia
Reference standard: NINCDS‐ADRDA; DSM‐IV. All participants received both reference standards.
Unclear whether clinicians conducting follow‐up were aware of the ¹⁸F‐FDG results.
Flow and timing Duration of follow‐up: mean 21.1 ± 10.9 months; mean 20.6 ± 10.3 MCI/MCI; mean 22.2 ± 12.4 MCI/ADD
At baseline: 36 MCI
At follow‐up: 11 converters; 22 non‐converters (Abstract)
Number included in analysis: 33
TP = 9; FN = 2; TN = 20; FP = 2 (Table 4, p 2197).
Sensitivity: 82%; specificity: 91% (calculated in Review Manager 5)
Loss to follow‐up: 3 participants excluded from the analysis: 2 no longer showed any cognitive objective deficit after 26 and 35 months, respectively, and were excluded from the study. Another participant developed fronto‐temporal dementia, according to the current criteria (Knopman 2005) after 1 year and was excluded.
Comparative  
Notes  
Methodological quality
Item Authors' judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Unclear    
Was a case‐control design avoided? Yes    
Did the study avoid inappropriate exclusions? Yes    
    Unclear Low
DOMAIN 2: Index Test All tests
Were the index test results interpreted without knowledge of the results of the reference standard? Yes    
If a threshold was used, was it pre‐specified? No    
    High Low
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target condition? Yes    
Were the reference standard results interpreted without knowledge of the results of the index tests? Unclear    
    Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and reference standard? No    
Did all patients receive the same reference standard? Yes    
Were all patients included in the analysis? No    
    High